Annual Total Expenses:
$463.85M-$27.83M(-5.66%)Summary
- As of today, HALO annual total expenses is $463.85 million, with the most recent change of -$27.83 million (-5.66%) on December 31, 2024.
- During the last 3 years, HALO annual total expenses has risen by +$296.44 million (+177.08%).
- HALO annual total expenses is now -5.66% below its all-time high of $491.68 million, reached on December 31, 2023.
Performance
HALO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$179.04M+$18.48M(+11.51%)Summary
- As of today, HALO quarterly total expenses is $179.04 million, with the most recent change of +$18.48 million (+11.51%) on September 30, 2025.
- Over the past year, HALO quarterly total expenses has increased by +$25.97 million (+16.96%).
- HALO quarterly total expenses is now at all-time high.
Performance
HALO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
HALO Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -5.7% | +17.0% |
| 3Y3 Years | +177.1% | +21.5% |
| 5Y5 Years | +76.0% | +515.1% |
HALO Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -5.7% | +177.1% | at high | +50.4% |
| 5Y | 5-Year | -5.7% | +276.1% | at high | +277.7% |
| All-Time | All-Time | -5.7% | >+9999.0% | at high | +277.7% |
HALO Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $179.04M(+11.5%) |
| Jun 2025 | - | $160.56M(+9.4%) |
| Mar 2025 | - | $146.77M(-8.8%) |
| Dec 2024 | $463.85M(-5.7%) | $161.00M(+5.2%) |
| Sep 2024 | - | $153.07M(+10.8%) |
| Jun 2024 | - | $138.11M(+16.0%) |
| Mar 2024 | - | $119.06M(-17.7%) |
| Dec 2023 | $491.68M(+25.2%) | $144.65M(+7.8%) |
| Sep 2023 | - | $134.20M(-8.3%) |
| Jun 2023 | - | $146.28M(+19.4%) |
| Mar 2023 | - | $122.53M(-1.0%) |
| Dec 2022 | $392.58M(+134.5%) | $123.79M(-16.0%) |
| Sep 2022 | - | $147.34M(+13.6%) |
| Jun 2022 | - | $129.68M(+126.8%) |
| Mar 2022 | - | $57.17M(+62.3%) |
| Dec 2021 | $167.41M(+35.7%) | $35.23M(+135.0%) |
| Sep 2021 | - | -$100.76M(-323.9%) |
| Jun 2021 | - | $45.00M(-26.4%) |
| Mar 2021 | - | $61.13M(+25.9%) |
| Dec 2020 | $123.34M(-53.2%) | $48.54M(+66.7%) |
| Sep 2020 | - | $29.11M(-1.0%) |
| Jun 2020 | - | $29.40M(-6.5%) |
| Mar 2020 | - | $31.46M(-64.3%) |
| Dec 2019 | $263.60M(+19.2%) | $88.06M(+23.6%) |
| Sep 2019 | - | $71.25M(+32.5%) |
| Jun 2019 | - | $53.77M(-2.5%) |
| Mar 2019 | - | $55.15M(-11.6%) |
| Dec 2018 | $221.19M(-6.1%) | $62.36M(+16.8%) |
| Sep 2018 | - | $53.41M(-8.1%) |
| Jun 2018 | - | $58.09M(-0.4%) |
| Mar 2018 | - | $58.33M(-11.2%) |
| Dec 2017 | $235.61M(+2.5%) | $65.68M(+7.7%) |
| Sep 2017 | - | $60.98M(-5.5%) |
| Jun 2017 | - | $64.51M(+3.3%) |
| Mar 2017 | - | $62.47M(-5.9%) |
| Dec 2016 | $229.90M(+41.5%) | $66.39M(+9.2%) |
| Sep 2016 | - | $60.80M(+1.0%) |
| Jun 2016 | - | $60.21M(-3.4%) |
| Mar 2016 | - | $62.31M(+30.1%) |
| Dec 2015 | $162.51M(+17.4%) | $47.91M(+5.9%) |
| Sep 2015 | - | $45.24M(+12.1%) |
| Jun 2015 | - | $40.37M(+19.5%) |
| Mar 2015 | - | $33.77M(-5.3%) |
| Dec 2014 | $138.37M(+2.3%) | $35.65M(+2.2%) |
| Sep 2014 | - | $34.89M(+0.7%) |
| Jun 2014 | - | $34.66M(-10.0%) |
| Mar 2014 | - | $38.51M(+11.7%) |
| Dec 2013 | $135.23M | $34.49M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $35.31M(-5.5%) |
| Jun 2013 | - | $37.37M(+20.1%) |
| Mar 2013 | - | $31.12M(+18.8%) |
| Dec 2012 | $95.95M(+26.4%) | $26.20M(+3.4%) |
| Sep 2012 | - | $25.34M(+16.4%) |
| Jun 2012 | - | $21.78M(-3.5%) |
| Mar 2012 | - | $22.56M(+8.3%) |
| Dec 2011 | $75.93M(+11.8%) | $20.83M(+17.2%) |
| Sep 2011 | - | $17.78M(-11.4%) |
| Jun 2011 | - | $20.07M(+16.8%) |
| Mar 2011 | - | $17.18M(-16.1%) |
| Dec 2010 | $67.88M(-5.9%) | $20.47M(+29.5%) |
| Sep 2010 | - | $15.81M(+2.9%) |
| Jun 2010 | - | $15.36M(+0.9%) |
| Mar 2010 | - | $15.23M(-20.3%) |
| Dec 2009 | $72.13M(+21.8%) | $19.11M(+12.8%) |
| Sep 2009 | - | $16.94M(-8.4%) |
| Jun 2009 | - | $18.49M(+5.6%) |
| Mar 2009 | - | $17.50M(-12.0%) |
| Dec 2008 | $59.20M(+85.3%) | $19.89M(+49.1%) |
| Sep 2008 | - | $13.33M(+7.2%) |
| Jun 2008 | - | $12.44M(+5.8%) |
| Mar 2008 | - | $11.76M(+17.1%) |
| Dec 2007 | $31.95M(+92.9%) | $10.05M(+26.0%) |
| Sep 2007 | - | $7.97M(+44.7%) |
| Jun 2007 | - | $5.51M(+32.2%) |
| Mar 2007 | - | $4.17M(-13.3%) |
| Dec 2006 | $16.56M(+21.0%) | $4.80M(+19.7%) |
| Sep 2006 | - | $4.01M(+19.7%) |
| Jun 2006 | - | $3.35M(-5.9%) |
| Mar 2006 | - | $3.56M(-0.2%) |
| Dec 2005 | $13.69M(+50.6%) | $3.57M(-4.2%) |
| Sep 2005 | - | $3.73M(+27.9%) |
| Jun 2005 | - | $2.91M(-8.7%) |
| Mar 2005 | - | $3.19M(+28.8%) |
| Dec 2004 | $9.09M(>+9900.0%) | $2.48M(-23.8%) |
| Sep 2004 | - | $3.25M(+56.8%) |
| Jun 2004 | - | $2.07M(+61.5%) |
| Mar 2004 | - | $1.28M(+2185.4%) |
| Dec 2003 | $0.00(0.0%) | $56.20K(+154.3%) |
| Sep 2003 | - | $22.10K(+72.7%) |
| Jun 2003 | - | $12.80K(+0.8%) |
| Mar 2003 | - | $12.70K(-84.2%) |
| Dec 2002 | $0.00(-100.0%) | $80.30K(+173.1%) |
| Sep 2002 | - | $29.40K(+23.0%) |
| Jun 2002 | - | $23.90K(+22.6%) |
| Mar 2002 | - | $19.50K |
| Dec 2001 | $64.40K | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual total expenses?
- What is the all-time high annual total expenses for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual total expenses year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly total expenses?
- What is the all-time high quarterly total expenses for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly total expenses year-on-year change?
What is Halozyme Therapeutics, Inc. annual total expenses?
The current annual total expenses of HALO is $463.85M
What is the all-time high annual total expenses for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual total expenses is $491.68M
What is Halozyme Therapeutics, Inc. annual total expenses year-on-year change?
Over the past year, HALO annual total expenses has changed by -$27.83M (-5.66%)
What is Halozyme Therapeutics, Inc. quarterly total expenses?
The current quarterly total expenses of HALO is $179.04M
What is the all-time high quarterly total expenses for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly total expenses is $179.04M
What is Halozyme Therapeutics, Inc. quarterly total expenses year-on-year change?
Over the past year, HALO quarterly total expenses has changed by +$25.97M (+16.96%)